ROSE K celebrates 30 years in the U.S.

2025.02.07

Menicon proudly marks the 30th anniversary of ROSE K approval in the United States, celebrating three decades of innovation and excellence in specialty contact lenses. This milestone was celebrated at the 2025 Global Specialty Lens Symposium (GSLS), where industry professionals gathered to recognize the lasting impact of ROSE K on keratoconus and irregular cornea management at a special reception hosted by Menicon.

Since its U.S. approval in 1995, ROSE K has remained one of the most widely prescribed lenses for keratoconus worldwide, offering patients enhanced vision and comfort. Menicon remains committed to supporting eye care professionals in providing the best lens designs for their patients and expanding access to them to as many people as possible.

"We are incredibly proud to celebrate 30 years of ROSE K in the U.S.," said Dr. Jennifer Choo, Global Director - Specialty Lens Division, Menicon. "This milestone reflects our dedication to continued innovation and our commitment to improving the lives of those with keratoconus and irregular cornea conditions. We extend our deepest gratitude to Paul Rose for developing this incredible family of lenses and to the wonderful eye care professionals who continue to use ROSE K to restore vision to their patients.  We look forward to continuing this legacy for years to come."